Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Competent Cells Market - Global Forecast to 2022 - Key Players are Thermo Fisher Scientific, Merck, New England Biolabs, Takara Bio, Promega Corporation, GenScript Biotech & Agilent Technologies - Research and Markets

Research and Markets
Posted on: 26 Jul 17

The "Competent Cells Market - Global Forecast to 2022" report has been added to Research and Markets' offering.

The global competent cells market is projected to reach USD 2.22 Billion by 2022 from USD 1.37 Billion in 2017, at a CAGR of 10.2%.

Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restraining the growth of this market.

The competent cells market is classified on the basis of type into chemically competent cells and electrocompetent cells. Electrocompetent cells are expected to grow at the highest CAGR during the forecast period. Electrocompetent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.

Based on application, the global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period. This segment comprises of mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation. The growth in this segment is primarily attributed to increasing intensity of research and technological advancements.

Companies Mentioned

  • Agilent Technologies, Inc.
  • Beijing Transgen Biotech Co., Ltd. (China)
  • Biodynamics Laboratory Inc. (Japan)
  • Bioline (U.K.)
  • Bio-Rad Laboratories, Inc.
  • Delphi Genetics (Belgium)
  • GCC Biotech (India)
  • Genescript Corporation (U.S.)
  • Genewiz (U.S.)
  • Genscript Biotech Corporation
  • IBA Gmbh (Germany)
  • Illumina, Inc.
  • Others

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Competent Cells Market, By Type

7 Competent Cells Market, By Application

8 Competent Cells Market, By End User

9 Competent Cells Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/ssnw8q/competent_cells

View source version on businesswire.com: http://www.businesswire.com/news/home/20170725005909/en/

Business Wire
www.businesswire.com

Last updated on: 26/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.